Effects of Elexacaftor/Tezacaftor/Ivacaftor on cough frequency, physical activity patterns, and sleep quality in adolescents and adults with cystic fibrosis
Journal of Cystic Fibrosis · 2026-07 · 25 (4) · 682-688
DOI: 10.1016/j.jcf.2026.03.016 ↗Kurz gefasst
Klinische Studie (Phase IV) in der Zeitschrift Journal of Cystic Fibrosis, 2026-07. Verfasst von Eva Van Braeckel und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium; Department of Internal Medicine and Paediatrics, Faculty of Medicine a…. Hauptthemen laut MEDLINE: Chloride Channel Agonists, Cough, Cystic Fibrosis, Exercise. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Vertex Pharmaceuticals Incorporated, National Institute for Health and Care Research.
Themen: Schlaf
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium; Department of Internal Medicine and Paediatrics, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium. Electronic addre…
- University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
- National Heart and Lung Institute, Imperial College London UK, Royal Brompton Hospital, part of Guy's and St Thomas' NHS Foundation Trust, London, UK.
- Manchester University NHS Foundation Trust, Manchester, UK; Division of Infection, Immunity and Respiratory Medicine, University of Manchester, Manchester, UK.
- Yale University, New Haven, CT, USA.
- Massachusetts General Hospital, Boston, MA, USA.
Förderung
- Vertex Pharmaceuticals Incorporated
- National Institute for Health and Care Research
Zitieren
APA
Van Braeckel, E., Braun, A. T., Simmonds, N. J., Barry, P. J., Davies, J. C., Egan, M. E., Lapey, A., Mall, M. A., McKone, E. F., Peckham, D., Proesmans, M., Ramsey, B., Santamaria, S. V., Smith, D., Taylor-Cousar, J. L., Tullis, E., De Wachter, E., Withers, N., Ahluwalia, N., …, & Keating, D. (2026). Effects of Elexacaftor/Tezacaftor/Ivacaftor on cough frequency, physical activity patterns, and sleep quality in adolescents and adults with cystic fibrosis. Journal of Cystic Fibrosis, 25(4), 682-688. https://doi.org/10.1016/j.jcf.2026.03.016
Vancouver
Van Braeckel E, Braun AT, Simmonds NJ, Barry PJ, Davies JC, Egan ME, et al. Effects of Elexacaftor/Tezacaftor/Ivacaftor on cough frequency, physical activity patterns, and sleep quality in adolescents and adults with cystic fibrosis. Journal of Cystic Fibrosis. 2026;25(4):682-688. doi:10.1016/j.jcf.2026.03.016
BibTeX
@article{VanBraeckel2026,
author = {Van Braeckel, Eva and Braun, Andrew T and Simmonds, Nicholas J and Barry, Peter J and Davies, Jane C and Egan, Marie E and Lapey, Allen and Mall, Marcus A and McKone, Edward F and Peckham, Daniel and Proesmans, Marijke and Ramsey, Bonnie and Santamaria, Saioa Vicente and Smith, Daniel and Taylor-Cousar, Jennifer L and Tullis, Elizabeth and De Wachter, Elke and Withers, Nick and Ahluwalia, Neil and Conner, Sarah and Jennings, Mark and Lou, Yiyue and Weinstock, Tanya G and Keating, Dominic},
title = {Effects of Elexacaftor/Tezacaftor/Ivacaftor on cough frequency, physical activity patterns, and sleep quality in adolescents and adults with cystic fibrosis},
journal = {Journal of Cystic Fibrosis},
year = {2026},
volume = {25},
number = {4},
pages = {682--688},
doi = {10.1016/j.jcf.2026.03.016}
}
EUVIMED